- Home
- TJX vs LLY Comparison
TJX vs LLY Comparison
Compare TJX & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TJX | LLY |
|---|---|---|
| Founded | 1962 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.6B | 979.6B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | TJX | LLY |
|---|---|---|
| Price | $164.83 | $1,108.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 19 |
| Target Price | $169.00 | ★ $1,218.84 |
| AVG Volume (30 Days) | ★ 4.8M | 2.4M |
| Earning Date | 05-20-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.23% | 0.81% |
| EPS Growth | 14.32 | ★ 95.99 |
| EPS | 1.19 | ★ 8.26 |
| Revenue | $29,078,407,000.00 | ★ $65,179,000,000.00 |
| Revenue This Year | $6.75 | $27.15 |
| Revenue Next Year | $5.81 | $16.04 |
| P/E Ratio | $137.96 | ★ $133.62 |
| Revenue Growth | 6.04 | ★ 44.70 |
| 52 Week Low | $119.84 | $623.78 |
| 52 Week High | $170.00 | $1,182.73 |
Technical Indicators
Market Signals| Indicator | TJX | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 58.93 | 56.02 |
| Support Level | $152.63 | $1,032.70 |
| Resistance Level | $170.00 | $1,108.78 |
| Average True Range (ATR) | 3.45 | 34.34 |
| MACD | 0.07 | -8.59 |
| Stochastic Oscillator | 67.47 | 42.35 |
Price Performance
Historical ComparisonAbout TJX TJX Companies Inc. (The)
Founded in 1987, TJX Companies is the world's largest off-price apparel and home fashions retailer, operating more than 5,000 stores across nine countries. In fiscal 2026, the company generated roughly $60 billion in sales. TJX operates through four segments: Marmaxx (61% of sales), HomeGoods (17%), TJX Canada (9%), and TJX international (13%). Its off-price model emphasizes branded merchandise at meaningful discounts, driving high traffic and rapid inventory turnover.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.